US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

45.33

-0.0435-0.10%

Post-market: 46.020.6925+1.53%19:30 EDT

Volume:1K

Turnover:49.11K

Market Cap:124.97M

PE:- -

High:46.37

Open:45.39

Low:45.33

Close:45.37

52wk High:48.78

52wk Low:27.68

Shares:2.76M

Float Shares:2.76M

Volume Ratio:0.38

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall

MT Newswires Live

Guardant Health to appeal federal district court judgment in TwinStrand case

Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents

THOMSON REUTERS

Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order

THOMSON REUTERS

Guardant Health to Appeal Federal District Court Judgment

THOMSON REUTERS

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Sector Update: Healthcare

MT Newswires Live

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live

Regenxbio reports FDA placed clinical hold on RGX-121

Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026

THOMSON REUTERS

Twinstrand: Delaware Court Enters Judgment on Aug. 21 in Favor of Co & University of Washington in Patent Infringement Suit Against Guardant Health

THOMSON REUTERS

Twinstrand: Under Judgment, Guardant Health Must Provide Co & Uw with Quarterly Accounting of All U.S. Sales of 11 Guardant Health Products & Services

THOMSON REUTERS

Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services

THOMSON REUTERS

Travere Therapeutics (TVTX) Is Up 6.1% After FILSPARI Beats FSGS Launch Expectations

Simply Wall St.

Regeneron’s Pasatru granted FDA approval for FOP

Is Spyre Therapeutics (SYRE) Fully Priced After Its SPY772 Program And SKYLIGHT Trial Launch?

Simply Wall St.

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units

Travere Therapeutics Director Gary A. Lyons Disposes of USD 629,150 in Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/LFSC/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":45.3275,"timestamp":1789156800000,"preClose":45.371,"halted":0,"volume":1074,"hourTrading":{"tag":"盘后","latestPrice":46.02,"preClose":45.3275,"latestTime":"19:30 EDT","volume":10,"amount":452.9875,"timestamp":1789169406017,"change":0.6925,"changeRate":0.015278,"amplitude":0},"delay":0,"changeRate":-0.0009587622049327025,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Market Closed","change":-0.0435,"latestTime":"09-11 16:00:00 EDT","open":45.39,"high":46.37,"low":45.3275,"amount":49106.001516000004,"amplitude":0.022977,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":45.371,"sharesOutstanding":2657035,"nav":45.4,"aum":125169389,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":46.02,"preClose":45.3275,"latestTime":"19:30 EDT","volume":10,"amount":452.9875,"timestamp":1789169406017,"change":0.6925,"changeRate":0.015278,"amplitude":0},"volumeRatio":0.3761557674902608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3761557674902608,"shares":2757035,"dividePrice":0,"high":46.37,"amplitude":0.022977,"preClose":45.371,"low":45.3275,"week52Low":27.6794,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":45.3275,"eps":0,"divideRate":0,"volume":1074,"delay":0,"ttmEps":0,"open":45.39,"prevYearClose":36.6147,"prevWeekClose":46.1341,"prevMonthClose":45.79,"prevQuarterClose":45.2033,"fiveDayClose":46.1466,"twentyDayClose":46.8217,"sixtyDayClose":40.4233},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662205974","title":"Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205974","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205974?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:41","pubTimestamp":1787600471,"startTime":"0","endTime":"0","summary":"Guardant Health  said Monday it will appeal the final judgment of a Delaware district court related to a patent infringement dispute with TwinStrand Biosciences and University of Washington.The company said execution of the court's final decision and collection of potential royalties are on hold, pending the appeal.The potential royalties do not apply to the company's current versions of Guardant Reveal and Shield, which feature updated technology. Additionally, the company has made design improvements to Guardant360 that would exclude the impact of potential ongoing royalties.The patents have also been preliminarily invalidated in separate challenges before the US Patent and Trademark Office, the company added.Shares fell around 3.5% in late afternoon trading.Price: 164.62, Change: -6.07, Percent Change: -3.56","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LFSC","GH","BK4535","BK4551","BK4588","LU0320765992.SGD","LU0889565916.HKD","BK4585","BK4196","GNOM","GNMX","GDOC","HELX","FFOX","LU0109394709.USD","EKG","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662030912","title":"Guardant Health to appeal federal district court judgment in TwinStrand case","url":"https://stock-news.laohu8.com/highlight/detail?id=2662030912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662030912?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:55","pubTimestamp":1787597714,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced it will appeal the final judgment from the U.S. District Court for the District of Delaware related to intellectual ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-to-appeal-federal-district-court-judgment-in-twinstrand-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-to-appeal-federal-district-court-judgment-in-twinstrand-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","LU0109394709.USD","PTH","HELX","GH","BK4196","GDOC","BK4588","FFOX","GNOM","LFSC","LU0320765992.SGD","BK4551","BK4535","LU0889565916.HKD","BK4585","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203463","title":"Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203463?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4535","GDOC","LU0320765992.SGD","BK4585","GNOM","BK4196","FFOX","GH","GNMX","HELX","BK4551","BK4588","PTH","LFSC","EKG","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203434","title":"Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203434","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203434?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GH","BK4588","BK4551","BK4196","BK4585","EKG","LU0320765992.SGD","PTH","GNMX","BK4535","FFOX","GDOC","LFSC","HELX","GNOM","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034312","title":"Guardant Health to Appeal Federal District Court Judgment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662034312?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","GH","PTH","EKG","LFSC","HELX","GNMX","LU0109394709.USD","BK4585","BK4588","LU0889565916.HKD","GDOC","BK4535","BK4551","LU0320765992.SGD","BK4196","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662520885","title":"U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2662520885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662520885?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:55","pubTimestamp":1787590534,"startTime":"0","endTime":"0","summary":"UPDATE 2-U.S. court orders Guardant to pay $245 million in DNA sequencing patent disputeAug 24 (Reuters)-A U.S. court has ordered Guardant Health to pay more than $245.2 million to TwinStrand Bioscien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L18D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","LU0889565916.HKD","GNOM","LU0053671581.USD","PTH","BK4196","BK4535","LU0320765992.SGD","BK4232","FFOX","BK4022","BK4551","GNMX","GH","LU0109394709.USD","SAIA","LFSC","BK4585","GDOC","BK4588","EKG","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","PBE","BK4588","BMED","JDOC","LFSC","IDNA","TMAT","WDNA","MEDX","BK4585","HELX","SYNB","IBB","XT","FDIF","GNOM","GDOC","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279439","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279439","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279439?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:58","pubTimestamp":1787576324,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF  0.4% higher and the iShares Biotechnology ETF  down 0.2%,Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said. Guardant Health stock was down more than 1% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","LU1894683264.USD","FFOX","IE0034235188.USD","IE00B3QW5Z07.USD","BK4535","EKG","STT","XBI","LU0109394709.USD","HELX","FDN","LU0889565916.HKD","LU0128526141.USD","LFSC","BK4585","HCSG","BK4196","BK4551","LU0029874061.USD","IE00BGHQF748.EUR","GDOC","GH","LU0320765992.SGD","XLV","BK4550","PTH","GNOM","BK4588","LU1894683348.USD","GNMX","BK4135","IE00B64PRP62.GBP","BK4581","LU1883839398.USD","LABU","IBB","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661752702","title":"Guardant Health Loses $245.2 Million Patent Infringement Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2661752702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661752702?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:51","pubTimestamp":1787572313,"startTime":"0","endTime":"0","summary":"Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said Monday.The final judgment, issued Friday, maintains a November 2023 jury verdict finding that Guardant Health willfully infringed two patents underlying TwinStrand's Duplex Sequencing technology in 11 royalty-bearing products and services, and awards TwinStrand and the University of Washington damages, accrued royalties and interest for infringement through May 31, 2026, the company said.The court ordered Guardant Health to pay a 6% royalty on sales of the covered products and services from June 1, 2026 until the expiration of the patents on March 15, 2033, the company said.Guardant is also required to provide quarterly accounting of US sales of the covered products and services, TwinStrand said.Guardant did not iimmediately reply to MT Newswires' request for comment.Shares of Guardant were down 1.6% in recent premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","GNMX","FFOX","GDOC","EKG","GNOM","LFSC","LU0320765992.SGD","LU0889565916.HKD","BK4551","PTH","BK4588","HELX","LU0109394709.USD","BK4585","BK4535","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627309","title":"Regenxbio reports FDA placed clinical hold on RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627309","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570406,"startTime":"0","endTime":"0","summary":"Regenxbio (RGNX) provided an update on its investigational gene therapy, RGX-121, for the treatment of Mucopolysaccharidosis type II, also known as...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","BK4585","IBBQ","LABU","FBT","SYNB","BK4505","IBB","RGNX","TBXU","LFSC","BK4563","BK4139","BK4588","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727387","title":"Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727387","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727387?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nP8N3M60G7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GH","FFOX","PTH","HELX","LU0320765992.SGD","BK4551","GDOC","LU0109394709.USD","EKG","GNOM","BK4535","GNMX","LFSC","BK4585","LU0889565916.HKD","BK4196","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661327802","title":"Twinstrand: Delaware Court Enters Judgment on Aug. 21 in Favor of Co & University of Washington in Patent Infringement Suit Against Guardant Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2661327802","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661327802?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nP8N3M60G7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","GDOC","LFSC","BK4196","BK4585","LU0320765992.SGD","GNMX","GNOM","HELX","LU0889565916.HKD","PTH","BK4551","BK4588","GH","LU0109394709.USD","EKG","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278025","title":"Twinstrand: Under Judgment, Guardant Health Must Provide Co & Uw with Quarterly Accounting of All U.S. Sales of 11 Guardant Health Products & Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278025","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278025?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nP8N3M60G7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4535","GDOC","LU0320765992.SGD","BK4585","GNOM","BK4196","FFOX","GH","GNMX","HELX","BK4551","BK4588","PTH","LFSC","EKG","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273336","title":"Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273336","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273336?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nP8N3M60G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU0320765992.SGD","BK4551","GH","EKG","GNOM","BK4585","BK4196","FFOX","GNMX","LFSC","LU0109394709.USD","HELX","PTH","GDOC","BK4535","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660323865","title":"Travere Therapeutics (TVTX) Is Up 6.1% After FILSPARI Beats FSGS Launch Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323865","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323865?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:32","pubTimestamp":1787232770,"startTime":"0","endTime":"0","summary":"Travere Therapeutics recently reported that FILSPARI’s launch in FSGS is outperforming expectations with broad physician demand across a U.S. pool of more than 30,000 biopsy-confirmed patients.\nThe company is also pushing its rare disease pipeline forward with a Phase III trial of pegtibatinase in classical homocystinuria and adding civorebrutinib for multiple renal indications affecting roughly 130,000 patients, underscoring a widening kidney-focused franchise.\nWe’ll now examine how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/travere-therapeutics-tvtx-is-up-61-after-filspari-beats-fsgs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/travere-therapeutics-tvtx-is-up-61-after-filspari-beats-fsgs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FFTY","TVTX","LFSC","FSGS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","FRTY","MRNX","TECB","BK4585","IDNA","IEIH","GDOC","IYH","BMED","LFSC","PSCH","RSPH","NVIB","IBB","BK4588","PINK","MEDI","TBXU","BBP","SYNB","LABU","XLVX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660406265","title":"Is Spyre Therapeutics (SYRE) Fully Priced After Its SPY772 Program And SKYLIGHT Trial Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660406265","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660406265?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:34","pubTimestamp":1787204046,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics stock reacts to new SPY772 program and SKYLIGHT trial launch\nSpyre Therapeutics (SYRE) is in focus after the company launched its SPY772 combination program and began SKYLIGHT, a Phase 2 proof of concept trial in Hidradenitis Suppurativa.\nBoth efforts target dual inhibition of TL1A and IL-17A/F in moderate to severe HS. The approach uses SPY072 alongside background bimekizumab therapy for around 150 adult participants.\nSee our latest analysis for Spyre Therapeutics.\nSpyre...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-syre/spyre-therapeutics/news/is-spyre-therapeutics-syre-fully-priced-after-its-spy772-pro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-syre/spyre-therapeutics/news/is-spyre-therapeutics-syre-fully-priced-after-its-spy772-pro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LFSC","BK4139","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028408","title":"Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028408","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:43","pubTimestamp":1787200984,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) just unveiled an announcement. Glenmark Pharmaceuticals has secured U.S. FDA approval for its F...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","PINK","XLVX","PSCH","FRTY","BBP","LFSC","BMED","MEDI","BK4585","TBXU","MRNY","SYNB","IYH","GDOC","IDNA","NVIB","BK4588","IEIH","GNMX","TECB","MRNX","LABU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479247","title":"Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479247?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:29","pubTimestamp":1787182181,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals released an interim H1 2026 results presentation outlining...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","SYNB","BK4585","GDOC","XT","TMAT","IBB","MEDX","LFSC","BK4139","BMED","GNMX","HELX","HTEC","IDNA","JDOC","TLX","GNOM","BK4588","WDNA","FDIF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660478716","title":"Travere Therapeutics Director Gary A. Lyons Disposes of USD 629,150 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660478716","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660478716?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169946,"startTime":"0","endTime":"0","summary":"Travere Therapeutics director Gary A. Lyons disposes of USD 629,150 in common sharesTravere Therapeutics director Gary A. Lyons sold 10,000 shares on Aug. 17-18 at about $62.53-$64.16.Sales followed o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL3ZcbDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Travere Therapeutics Director Gary A. Lyons Disposes of USD 629,150 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LFSC","TVTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}